Biosana Pharma Overview
- Founded
-
2012
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$17M
- Investors
-
2
Biosana Pharma General Information
Description
Operator of a biopharmaceutical company intended to focus on reducing the manufacturing costs of monoclonal antibody biological drugs. The company engages in the development and production of monoclonal antibodies with a focus on biosimilars, allowing medical businesses with good profitability with less manufacturing costs.
Contact Information
Website
www.biosanapharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Primary Office
- Bargelaan 200
- 2333 CW Leiden
- Netherlands
+31 06 00000000
Biosana Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series C) | 03-Dec-2020 | $17M | 0000 | Completed | Generating Revenue | |
| 4. Later Stage VC | 01-Jan-2017 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 01-Dec-2015 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 01-Jan-2015 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Startup |
Biosana Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Biosana Pharma Patents
Biosana Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-9982226-B2 | Discontinuous fed batch processing with the use of alternating bioreactors | Active | 09-Nov-2012 | 000000000 | |
| AU-2013341858-A1 | Discontinuous fed batch processing with the use of alternating bioreactors | Active | 09-Nov-2012 | 000000000 | |
| AU-2013341858-B2 | Discontinuous fed batch processing with the use of alternating bioreactors | Active | 09-Nov-2012 | 000000000 | |
| CA-2890813-C | Discontinuous fed batch processing with the use of alternating bioreactors | Active | 09-Nov-2012 | 000000000 | |
| CA-2890813-A1 | Discontinuous fed batch processing with the use of alternating bioreactors | Active | 09-Nov-2012 | C12M47/10 |
Biosana Pharma Executive Team (6)
Biosana Pharma Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Ard Tijsterman | Biosana Pharma | Co-Founder, Co-Owner, Chief Executive Officer & Board Member | 000 0000 |
| Edward Willems | Self | Board Member | 000 0000 |
| Engelbert Willink MD | Self | Board Member | 000 0000 |
| Jan Mak | Self | Board Member | 000 0000 |
| Phil Blackshaw | Biosana Pharma | Board Member | 000 0000 |
Biosana Pharma Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Biosana Pharma Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Gold Nest Private Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Cicada Innovations | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |
Biosana Pharma Investments & Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 | 01-Jan-2018 | 0000000000 | Biotechnology | ||
| BiOraliX | 01-Oct-2017 | Joint Venture | Biotechnology |
Biosana Pharma Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 00000000 | Biotechnology | Fochteloo, Netherlands | 0000 |